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Emily Williams: The Effects of Nicotinamide on Reinstatement to Cocaine Seeking 
(Under the direction of Kathryn Reissner) 
 
Interventions for psychostimulant use disorders are of significant need. Nicotinamide 
(NAM) is a small molecule that can oppose cellular adaptations observed following cocaine use 
in a preclinical rodent self-administration model of addiction. In addition, utility of NAM against 
symptoms of withdrawal and vulnerability to relapse to cocaine use has been suggested by case 
studies and anecdotal reports. However, the empirical effects of nicotinamide on drug seeking 
behaviors have not been examined. The objective of the current study was to investigate the 
effects of systemic NAM administration on reinstatement to cocaine seeking, using the rat self-
administration/extinction/reinstatement model of cocaine addiction. Male and female Sprague-
Dawley rats were trained to self-administer i.v. cocaine or food pellets for 2 hrs per day for 12 
days, followed by 14-17 days of extinction, during which i.p. NAM injections (0-120 mg/kg) 
were given 30 minutes prior to each extinction or reinstatement session. Rats were tested on cue-
primed, cocaine-primed, or food-primed reinstatement, as well as locomotor activity. Chronic 
NAM administered throughout extinction dose-dependently attenuated cue-primed reinstatement 
in male rats, but not female rats. In contrast, acute NAM given once prior to reinstatement had no 
effect on reinstatement. Chronic NAM had no effect on locomotor activity or reinstatement to 
food seeking. The specificity of NAM against cue-primed reinstatement indicates that NAM may 
influence responsiveness to drug-associated cues, specifically in males. Future studies will 
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CHAPTER 1: INTRODUCTION 
Nicotinamide (NAM), a form of vitamin B3, component of crucial coenzymes NAD+ and 
NADP+, and free radical scavenger, is widely used clinically to treat pellagra (niacin deficiency), 
bullous pemphigoid, acne and rosacea, atopic dermatitis, and skin photoageing (Mutasim, 2003; 
Surjana & Damian, 2011). It also shows promise in preserving and enhancing neurocognitive 
function in a variety disease models such as Alzheimer’s, traumatic brain injury (ischemia and 
contusion injury), and Parkinson’s disease (Rennie, Chen, Dhillon, Vardy, & Damian, 2015). In 
addition, NAM has been proposed as an effective treatment for substance abuse (Namazi, 2004; 
Otte, Borelli, & Korting, 2005); however, empirical scientific evidence for this is lacking. 
Nevertheless, several cellular functions of NAM indicate that it may be beneficial in opposing 
cellular adaptations that mediate cocaine seeking in a preclinical rodent model of addiction, 
including consequences of oxidative stress and compromised cellular metabolic functions. 
Oxidative Stress 
NAM is a free radical scavenger that protects against cellular oxidative stress (OS) as 
well as reactive oxygen species (ROS) following oxidative stress (Bayrakdar et al., 2014; Negi, 
Kumar, Kaundal, Gulati, & Sharma, 2010; Song et al., 2017).  Cocaine exposure in vitro as well 
as in vivo increases the expression of OS biomarkers including 8-hydroxyguanine (8-OHG), in 
the nucleus accumbens (NAc) (Jang et al., 2015), as well as superoxide dismutase and 
malondialdehyde in the frontal cortex, hippocampus, and dorsal striatum (Pomierny-Chamiolo, 
Moniczewski, Wydra, Suder, & Filip, 2013; Steinmetz et al., 2018). Elevated levels of ROS 
following OS induce damage to DNA, lipids, and proteins (Schieber & Chandel, 2014).  
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Importantly, levels of ROS have been linked to cocaine seeking, as administration of ROS 
scavengers leads to a reduction in cocaine self-administration as well as attenuation of cocaine-
induced enhancement of dopamine (DA) release (Jang et al., 2015). In addition, in comparison to 
animals who were assigned to a cocaine yoke procedure, animals who voluntarily self-administer 
cocaine show significantly altered expression of oxidative stress biomarkers in the hippocampus, 
frontal cortex, and dorsal striatum (Pomierny-Chamiolo et al., 2013).  
In response to ROS-induced DNA damage, upregulation of the DNA repair enzyme, 
poly(ADP-ribose)polymerase (PARP-1) (Jiang et al., 2018; Lonskaya et al., 2005) is also found. 
PARP-1 expression and activity is also upregulated within the rodent brain following both non-
contingent cocaine and cocaine self-administration (Lax et al., 2017; Scobie et al., 2014) and 
expression is also increased in the brains of human cocaine addicts (Alvaro-Bartolome, La 
Harpe, Callado, Meana, & Garcia-Sevilla, 2011).   Beyond the role of PARP-1 as a DNA repair 
enzyme, PARP-1 serves as a component in transcriptional regulation, poly(ADP-ribosyl)ation 
(PARylation) of various cellular targets (Gupte, Liu, & Kraus, 2017; Kraus & Hottiger, 2013), 
and is suggested to promote the motivational aspects of chronic cocaine use. For example, 
experimental overexpression of PARP-1 promotes cocaine conditioned place preference (CPP), 
increases self-administration of low cocaine doses, and augments locomotor responses to cocaine 
(Lax et al., 2017; Scobie et al., 2014). As mentioned, NAM attenuates ROS levels and protects 
against cellular oxidative stress (Bayrakdar et al., 2014; Negi et al., 2010; Song et al., 2017); 
however, NAM is also an inhibitor of PARP-1 (Javle & Curtin, 2011; Riklis, Kol, & Marko, 
1990). Given that inhibition of PARP-1 is found to reduce cocaine CPP (Lax et al., 2017), this 




NAD+ signaling and mitochondrial functioning 
In addition, chronic cocaine also impairs both NAD+ signaling and mitochondrial 
function (de Oliveira & Jardim, 2016; Logan et al., 2018). NAD+ is important for energy 
homeostasis and calcium transport in the brain (Liang et al., 2017; Tamsett, Picchione, & 
Bhattacharjee, 2009; Ying, 2007) and is depleted following DA stimulation (Requardt et al., 
2012; Requardt, Wilhelm, Rillich, Winkler, & Hirrlinger, 2010). Within neuronal mitochondria 
isolated from 9-12 week old rats, cocaine impairs mitochondrial respiration (Cunha-Oliveira et 
al., 2013), and disrupts the mitochondrial membrane potential of mitochondria in cultured 
neurons (Cunha-Oliveira et al., 2006; Yao, Allen, Zhu, Callen, & Buch, 2009). Cocaine exposure 
also results in in disrupted mitochondrial membrane potential within the mitochondria of 
cultured astrocytes (Yang, Yao, Lu, Wang, & Buch, 2010). As mentioned previously, NAM 
serves as a means to increase the bioavailability of NAD+ and other coenzymes crucial to 
mitochondrial functioning (Fricker, Green, Jenkins, & Griffin, 2018). Given that the many 
mitochondrial processes depend both on NAD+ and its phosphorylated counterpart NADP, the 
availability and redox state of NAD+ has important influence on all major mitochondrial 
processes (Dolle, Rack, & Ziegler, 2013). As a precursor to NAD+, NAM administration may 
therefore combat cocaine dependent disruptions in NAD+ signaling and mitochondrial 
functioning. 
Based on evidence that chronic i.p. NAM can reduce oxidative stress (Turunc Bayrakdar, 
Uyanikgil, Kanit, Koylu, & Yalcin, 2014), PARP-1 activity (Guzyk et al., 2016; Virag & Szabo, 
2002), and increase protective NAD+ levels (C. Wang et al., 2017) we sought to determine 
whether chronic i.p administration of NAM would influence reinstatement to cocaine seeking.  
Five experiments were performed in order to test this hypothesis. The first experiment was 
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designed to investigate the effects of chronic NAM on both cue-primed and cocaine-primed 
reinstatement in male and female rats. The second experiment was designed to investigate 
whether chronic NAM administration would affect locomotor behavior or locomotor responses 
to cocaine in male rats. Next, the effect of chronic NAM administration on cocaine-reinstatement 
in isolation was examined. The fourth experiment was to investigate whether chronic NAM was 
necessary to affect reinstatement in male rats; therefore, NAM was given acutely prior to the cue 
and cocaine-primed reinstatement sessions following cocaine self-administration and extinction. 






































CHAPTER 2: METHODS AND MATERIALS 
 
Subjects and reagents 
Male (225-250g upon arrival, Envigo) and female (175-200g upon arrival, Envigo) 
Sprague-Dawley rats, were housed individually in a temperature-controlled environment (20-21° 
C) on a 12-h reverse light cycle (7 am off, 7 pm on). Prior to the start of experimental 
procedures, rats were maintained on ad libitum food and were given unlimited water access 
throughout the experiment. Treatment and housing of animals was approved by the University of 
North Carolina Institutional Animal Care and Use Committee and followed the “Guide for the 
Care and Use of Laboratory Rats” (Institute of Laboratory Animal Resources on Life Sciences, 
National Research Council, 1996). Cocaine was generously provided by the NIH Drug Supply 
Program. Nicotinamide was purchased from Sigma-Aldrich (catalog #72340) and prepared in 
saline.  
Surgical Procedures  
Rats were anesthetized with ketamine (100 mg/kg, i.m.) and xylazine (7 mg/kg, i.m.). 
Custom in-house indwelling catheters for self-administration were then surgically implanted into 
the right jugular vein to allow for i.v. cocaine delivery, described previously by (Fuchs, Eaddy, 
Su, & Bell, 2007; Scofield et al., 2016). Catheter tubing ran from the jugular vein subcutaneously 
and exited between the shoulder blades of the animal to be capped securely with sealed tygon 
tubing. At least five days of post-operative care and recovery were allotted for all animals prior 
to the initiation of cocaine self-administration. Throughout recovery, as well as for the duration 
of self-administration procedures, 0.1 mL gentamicin (5 mg/mL) and 0.1 mL heparinized saline 
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(100U/mL) were administered i.v. To check for catheter patency, propofol (1 mg/0.1 mL, i.v.) 
was administered prior to the onset of self-administration and subsequently as needed. 
Behavioral Training 
 Before surgery, rats were trained to lever press for food pellets (45 mg pellets; Bio Serv, 
Flemington, NJ) under an FR1 reinforcement schedule. Food training and self-administration 
sessions were performed in sound attenuated, standard operant conditioning chambers (Med 
Associates, St. Albans, VT). Each chamber was equipped with two retractable levers divided by 
a food pellet dispenser. Starting 24 hours prior to food training session, rats received rations of 
approximately 20g of chow daily. Lever presses on the active lever during training sessions 
resulting in the delivery of one food pellet (Bio Serv, Flemington, NJ). Presses on the inactive 
lever had no consequences for the entirety of the training session. Training session continued 
until animals reached a criterion of 100 active lever presses or 8 hours had elapsed. 
 For all self-administration sessions, rats completed 12 days of cocaine self-administration 
with a minimum criterion of 10 infusions per day (0.75 mg/kg/infusion, 2 h/day), followed 
immediately by 14-17 days of extinction training. Active lever presses during cocaine self-
administration sessions resulted in delivery of a cocaine infusion, as well as the illumination of a 
stimulus light above the active lever and a tone presentation. Both cues were presented 
simultaneously for a programed duration of five seconds. A 20 second timeout was enacted 
following the delivery of each infusion during which time active lever presses were recorded, but 
had no consequences. Inactive lever presses during cocaine self-administration sessions had no 
programmed responses for the entirety of the session. During extinction, presses on the active 
lever no longer resulted in cocaine infusions, lights, or tone presentation. Similarly, presses on 
the inactive lever maintained the lack of programmed responses during extinction. 
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Experiment 1: Effects of Chronic NAM administration on cue- and cocaine-primed 
reinstatement in males and females 
 
A timeline for the experiment can be seen in Figure 1A. Given the relatively short half-life of 
NAM (100 mg/kg: 3.4 hours), rats were given daily i.p. injections of NAM (10 mg/kg, 30 mg/kg, 
60 mg/kg, or 120 mg/kg; 1 mL/kg) or saline 30 minutes prior to every extinction session and 
subsequent reinstatement tests (Stratford & Dennis, 1994). Twenty-four hours following the last 
extinction session, rats were tested on a 2h cue-primed reinstatement session. This session began 
with a five second presentation of the light and tone cues which had been previously presented 
during self-administration. All subsequent active lever presses resulted in identical light and tone 
cue presentations without delivery of cocaine. Inactive lever presses were recorded, but 
maintained a lack of programmed consequences. Cue-primed reinstatement was followed by a 
return to extinction sessions for three days to return to baseline extinction pressing. Following 
the third extinction session, animals were tested on a cocaine-primed reinstatement test. For this 
reinstatement session, animals received NAM or saline i.p. 30 minutes prior to the session, just 
as in extinction and cue-primed reinstatement testing. However, immediately before entering the 
chambers, animals were given a 10 mg/kg i.p. injection of cocaine.  Active and inactive lever 
presses during cocaine-primed reinstatement did not result in the delivery of light or tone cues.  
 Based upon the dose responsiveness to NAM observed in male rats, the effects of 120 
mg/kg NAM on cue- and cocaine-primed reinstatement were examined as described above in 
female rats. Beginning 4 days prior to the end of extinction, subjects received vaginal swabs 
daily after completion of the experimental session. This continued until the end of all 
experimental sessions; 9-10 days in total. Vaginal swabs were transferred to glass slides, allowed 
to dry and stained with Wright’s Stain (Fisher Chemical W35-25) for later examination. Cell 
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type identification was made microscopically consulting methods by Cora, Kooistra, and Travlos 
(2015); Zenclussen, Casalis, Jensen, Woidacki, and Zenclussen (2014) 
Experiment 2: Effects of Chronic NAM administration on locomotion 
 To examine if the effects of effects on responding were due to locomotor sedative effects, 
open field locomotor activity was assessed in the same cohort of rats used for reinstatement 
testing. Prior to locomotor testing, animals remained in their home cages 1-5 days following the 
final reinstatement procedure; injections of NAM or saline were given daily. On the day of 
locomotor testing, rats were given NAM or saline injections 30 minutes before being placed into 
standard locomotor chambers (Med Associates, St. Albans, VT). Locomotor behavior was 
recorded for a total of 2h. At the one-hour time point, all animals were given a 10 mg/kg i.p. 
injection of cocaine and returned to the chamber to continue locomotor recording for the second 
hour. 
Experiment 3: Effect of chronic NAM administration on cocaine-primed reinstatement alone  
In order to control for any possible ordering effects of the reinstatement test sessions, a separate 
cohort of rats was given only a cocaine-primed reinstatement session following extinction. All 
other procedures were identical to experiment 1. A timeline for the experiment can be seen in 
Figure 2A 
Experiment 4: Effects of Acute NAM administration on cue- and cocaine-primed 
reinstatement 
 
 To determine whether or not chronic NAM administration was necessary to produce 
effects on reinstatement responding, animals completed cocaine self-administration and 
extinction as in Experiment 1; however NAM injections were only given once, 30 min prior to 




Experiment 5: Effects of Chronic NAM administration on Food Reinstatement 
 In an effort to determine whether or not the effects of NAM administration on 
reinstatement are specific to drug reinforcers, a cohort of animals completed a food self-
administration, extinction, and reinstatement paradigm as previously described by Cosme, 
Gutman, and LaLumiere (2015) and McFarland and Kalivas (2001). Briefly described, animals 
initially pressed on the active lever for an FR1 schedule for delivery of a 45 mg food pellet, 
followed progressively by sessions on FR3 and FR5 reinforcement schedules. Each rat was 
required to press for at least 100 food pellets per day for at least three days in order to progress to 
the next schedule of reinforcement. Completion of each reinforcement schedule also resulted in 
the presentation of both the light and tone cue for 5 seconds. After these criteria were reached on 
the FR5 schedule, extinction procedures began. As for cocaine studies, NAM (120 mg/kg) or 
saline injections began on day 1 of extinction and continued for the remaining duration of the 
experimental sessions. For food-primed reinstatement, two food pellets were placed in the food 
hoppers before the session began. During the first 30 minutes of the session, a single food pellet 
was delivered non-contingently every two minutes; the remaining time proceeded as a typical 
extinction session. Presses on either lever had no programmed consequences for the entire 
duration of the session. An experimental timeline can be seen in Figure 4A.  
Data Analysis 
 Statistical analysis was performed using Prism 7 software. For self-administration and 
extinction measures, two-way repeated measures ANOVA were performed with day and group 
(NAM: 10 mg/kg, 30 mg/kg, 60 mg/kg, 120 mg/kg or SAL) as factors. Active lever presses and 
the number of infusions or food pellets received throughout self-administration were considered 
dependent variables. To confirm an effect of reinstatement, a two-way ANOVA was used to 
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compare active lever presses on the last day of extinction and active lever pressing on the tests of 
reinstatement of NAM and SAL animals. Sidak's multiple comparisons test was used to examine 
whether each group or dose displayed an increase in active lever pressing in comparison to the 
final day of extinction. For locomotor tests, two-way repeated measures ANOVA was performed 
with time (5 minute bins) and group (NAM: 10 mg/kg, 30 mg/kg, 60 mg/kg, 120 mg/kg or SAL) 
as factors. Tukey’s multiple comparisons test was used to examine whether locomotor behavior 
increased in all groups due to administration of cocaine at the 1 hour time-point. One-way 
ANOVAs were performed to examine differences between groups in the total distance traveled 






















CHAPTER 3: RESULTS 
 
Experiment 1: Chronic NAM administration reduces cue- but not cocaine-primed 
reinstatement in males but not females 
 
 Experimental timeline is shown in Figure 1A. Following 12 days of cocaine self-
administration, male rats were treated with varying doses of NAM prior to each extinction and 
reinstatement session. Prior to receiving NAM, future treatment groups did not differ across days 
on active lever presses (no main effect of group (F(4,53) = 0.363, p = 0.834) or interaction 
between group and day (F(44, 583) = 0.579, p = 0.987); note that for clarity, active lever 
pressing among future treatment groups are shown together in the self-administration stage). 
Likewise, future treatment groups did not differ on reinforcers earned during self-administration, 
prior to receiving NAM or SAL (data not shown, no main effect of group (F(4, 53) = 2.354, p = 
0.066) or interaction between group and day (F(44, 583) = 0.704, p = 0.926)). There were no 
significant differences between treatment groups during extinction (Fig. 1B; F(4,53) = 0.334; p = 
0.854). All groups demonstrated significant cue-primed reinstatement (Fig 1C; F(1,50) = 163, p 
< 0.0001; 10 mg/kg: p < 0.0001, 30 mg/kg: p < 0.0001, 60 mg/kg: p < 0.001, 120 mg/kg: p = 
0.005, SAL: p < 0.0001) and cocaine-primed reinstatement (F(1,49) = 73.1, p < 0.0001, 10 
mg/kg: p < 0.01, 30 mg/kg: p < 0.05, 60 mg/kg: p < 0.01, 120 mg/kg: p = 0.0001, SAL: p < 
0.001). A dose-dependent effect of NAM on active lever responding was observed during cue-
primed reinstatement (Fig. 1C; (F(4, 50) = 3.105, p < 0.05)). Tukey’s multiple comparisons 
revealed that the 60 mg/kg (p < 0.05) and 120 mg/kg (p < 0.001) treatment group responded 
significantly less on the active lever than the saline treatment group. Additionally, the 120 mg/kg 
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group also pressed significantly less than the 10 mg/kg group (p < 0.05). Following cue-primed 
reinstatement, rats underwent three additional extinction sessions, followed by a cocaine-primed 
reinstatement test. No effect of NAM treatment was observed on subsequent cocaine-primed 
reinstatement (Fig. 1D; F(4, 49) = 0.331, p = 0.856).  
 Self-administration and extinction data for female rats are shown in Figure 1E. Prior to 
receiving NAM or SAL injections, future groups did not differ on active lever presses (F(1, 23) = 
1.088, p = 0.308) or reinforcers earned  (F(1, 23) = 2.294, p = 0.144). Both treatment groups 
demonstrated significant cue-primed reinstatement (F(1,23) = 57.32, p < 0.0001; SAL: p = 0.001, 
NAM: p < 0.0001) and cocaine-primed reinstatement (F(1,23) = 19.49, p < 0.001: SAL: p <0.05, 
NAM: p < 0.005); however, there were no significant differences between NAM and SAL group 
active lever presses during the cue-primed reinstatement session (Fig. 1F, F(1,23) = 2.505, p = 
0.127). Likewise, no significant differences were found between the active lever presses of NAM 
or SAL groups during the cocaine-primed reinstatement (Fig. 1G, F(1,23) = 0.355, p =0.557). 
For cue-primed reinstatement a total of 17 animals were in proestrous (8 SAL, 9 NAM); 6 
animals were in estrous (4 SAL, 2 NAM); 2 animals were in metestrous (0 SAL, 2 NAM); no 
animals were in diestrous. For cocaine-primed reinstatement, a total of 14 animals were in 
proestrous (6 SAL, 8 NAM); 5 animals were in estrous (5 SAL, 0 NAM); 5 animals were in 
metestrous (1 SAL, 4 NAM); 1 animal was in diestrous (0 SAL, 1 NAM). Behavioral 
comparisons between estrus stages within groups were not performed, due to the unequal 





Experiment 2: Chronic NAM administration has no effects on open-field locomotor or 
cocaine-primed locomotor 
The same cohort of male animals from experiment 1 were tested on open field and 
cocaine-induced locomotor 30 minutes following a NAM injection; results are shown in Figure 
1H-J. There were no differences between groups at any time point during the entire 120 minutes 
(Fig. 1H, F (4,49) = 1.045, p = 0.394). There was no interaction (F(92, 1127) = 1.07, p = 0.312) 
and no main effect of group (F(4, 49) = 1.045, p = 0.394) but there was a significant main effect 
of time (F(23, 1127) = 116.4, p <0.0001). Tukey’s multiple comparison tests revealed that for all 
groups distance traveled (cm) increased following an injection of cocaine (p < 0.0001). There 
were no differences between groups in total distance traveled during the first 60 minutes of open 
field testing (Fig. 1I, F(4,49) = 1.886, p = 0.128) or during the final 60 minutes following 
experimenter administration of cocaine (Fig. 1J, F(4, 49) = 0.981, p = 0.427).  
Experiment 3: Chronic NAM administration had no effect on cocaine-primed reinstatement. 
 
   Experiment 1 indicates that chronic NAM had no effect on a test of cocaine-primed 
reinstatement when it occurred subsequent to a cue-primed reinstatement. In order to determine 
whether this lack of effect on cocaine-primed reinstatement might be due to an ordering effect 
associated with multiple reinstatement tests, a separate cohort of animals was chronically 
administered 120 mg/kg NAM or saline during extinction and then tested on cocaine 
reinstatement only; results are shown in Figure 2. Prior to receiving NAM injections, groups did 
not show a significant difference in active lever presses (Fig 2B, F(1,11) = 3.189, p = 0.10) 
during self-administration or reinforcers earned (F(1, 11) = 0.018, p = 0.896). Both groups 
demonstrated significant cocaine-primed reinstatement behavior (F(1,11) = 15.02, p < 0.005: 
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SAL p = 0.05, NAM p < 0.05); however, treatment groups did not differ on active lever pressing 
during cocaine-primed reinstatement (Fig. 2C, F(1,11) = 0.134, p = 0.721).  
Experiment 4: Acute NAM administration does not affect cue- or cocaine-primed 
reinstatement 
 
Self-administration and extinction data for experiment 4 are shown in Figure 3B. Prior to 
receiving any NAM or saline, neither lever pressing behavior nor reinforcers earned differed 
across future groups (active lever pressing: (F(1, 144) = 0.543; p = 0.462); reinforcers earned: 
(F(1,144) = 0.695; p = 0.406).  In contrast to chronic administration of NAM across extinction, 
there was no effect of acute 120 mg/kg NAM on active lever responding during cue-primed 
reinstatement (Fig. 3C, effect of reinstatement: F(1,12) = 39.93, p < 0.0001 SAL p < 0.005, 
NAM p < 0.005; F(1,12) = 0.092, p = 0.766). Likewise, there was no effect of acute 120 mg/kg 
NAM on cocaine-primed reinstatement (Fig. 3D, effect of reinstatement: F(1,12) = 26.87, p < 
0.001, SAL p < 0.01, NAM p < 0.01; F(1,12) = 0.1213, p = 0.7337).   
Experiment 5: Chronic NAM administration did not reduce cue or food-primed reinstatement  
 
Food self-administration, extinction, and reinstatement data are shown in Figure 4B. Prior 
to receiving NAM or SAL injections, lever pressing or reinforcers earned did not differ across 
future groups (active lever pressing: (F (1, 14) = 0.289; p = .600); reinforcers earned: (F (1, 14) = 
1.011; p = 0.332). A two-way ANOVA revealed a significant interaction between group and 
session during extinction (F(14, 196) = 6.104; p < 0.0001). Sidak’s multiple comparisons reveled 
that the NAM group had significantly fewer active lever presses on day 1 of extinction than the 
saline group (p <0.0001). Active lever pressing the remaining days was not significantly 
different between groups (p > 0.9999). A two-way ANOVA revealed a significant effect of cue-
primed reinstatement in comparison to extinction active lever pressing (F(1,14) = 7.646, p < 
0.05) however Sidak’s multiple comparisons reveled that neither group pressed significantly 
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higher in the cue-primed reinstatement session than they did in extinction (NAM: p = 0.168, 
SAL: p = 0.111). There were no differences in active lever presses between groups on the cue-
primed reinstatement session (Fig. 4C, F(1, 14) = 2.15, p = 0.165).  There was a significant effect 
of reinstatement for food-primed reinstatement (F(1,14) = 23.11, p < 0.001). Sidak’s multiple 
comparisons revealed that both groups pressed significantly more in the food-primed 
reinstatement session than during extinction (NAM: p < 0.01, SAL: p <0.01). There was no 
























CHAPTER 4: DISCUSSION 
Discussion 
Results of the current study indicate that chronic, but not acute, systemic administration 
of NAM specifically reduces responding in cue-primed, but not cocaine-primed reinstatement in 
male rats but not female rats. This effect on cue-primed reinstatement is likely not due to a 
generalized sedative effect, motor effect, or generalized effect on motivation, as both locomotor 
activity, cocaine-primed reinstatement, and food reinstatement were unaffected.  
Therapeutic Uses of Nicotinamide  
NAM shows promise as a being preventative for non-melanoma skin cancers (Surjana, 
Halliday, Martin, Moloney, & Damian, 2012) and has neuroprotective effects in animal models 
of Alzheimer’s, traumatic brain injury (ischemia and contusion injury), and Parkinson’s disease 
(for full review see: (Rennie et al., 2015). Within these animal models NAM treatment is known 
to produce behavioral changes as well, including improved short-term and long-term memory in 
Alzheimer’s disease model mice (Green et al., 2008), improved reference memory acquisition 
and reversal learning in post-cortical contusion injury rats (Peterson, Anderson, Kantor, & 
Hoane, 2012), and improved motor functioning in Parkinson’s disease model mice (Xu et al., 
2012). When administered in combination with tryptophan, early studies indicated that NAM 
treatment may improve depression symptomology in humans (Chouinard, Young, Annable, & 
Sourkes, 1977; Chouinard, Young, Annable, Sourkes, & Kiriakos, 1978) and NAM 
administration alone in rats prevents the development of a subordinate status in animals that were 
experimentally characterized as ‘highly anxious’ (Hollis et al., 2015). With respect to addiction, 
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although NAM has been suggested by some to be a potential “anti-addiction weapon,”(Namazi, 
2004), to our knowledge, there are no existing empirical scientific studies that examine NAM 
treatment in the context of drug self-administration, extinction, and reinstatement.  
Cocaine Cue-primed Reinstatement Specificity 
 Our results suggest that the effects of NAM are specific to reducing cue-primed 
reinstatement. Examination of neural circuitry involved in different modalities of reinstatement 
unsurprisingly reflects that different stimuli engage overlapping yet distinct circuits. Of 
particular interest in regard to cue-primed reinstatement are the basolateral amygdala (BLA) and 
the central amygdala (CeA), as inactivation of these areas reduces cue-primed reinstatement 
(Feltenstein & See, 2008; See, 2005) but not cocaine-primed reinstatement (Grimm & See, 2000; 
McFarland & Kalivas, 2001). Though none have examined the effects of NAM, PARP-1 
inhibition, or NAD+ supplementation in a reinstatement model, PARP-1 inhibition in the CeA 
but not the BLA reduces cocaine conditioned place preference (CPP) (Lax et al., 2017). 
Additionally, Lax et al. (2017) found that while PARP-1 was significantly activated in the CeA, 
it was not significantly increased in the BLA further implicating the potential specificity of 
PARP-1 effects in the CeA. The differential circuitry of cue-primed and cocaine-primed 
reinstatement suggests that the effects of NAM may be primarily influential within the amygdala. 
The importance and mechanistic effects of NAM within the CeA is yet to be determined and 
requires further study within a reinstatement model.  
 Chronic NAM administration did not block the cue-primed or food-primed reinstatement 
of rats following food self-administration and extinction. This finding suggests that the effects of 
NAM may be specifically beneficial in response to neuroadaptations caused by cocaine self-
administration rather than generalized reward seeking behaviors. Likewise, in addition to the 
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lack of effect of NAM any locomotor activity, this further confirms the lack of any generalized 
motor or motivational effect of chronic NAM.  
 Nicotinamide and Sex differences 
While NAM dose-dependently reduced cue-primed reinstatement in male rats, it was 
without effect in females. In order to investigate potential avenues of explanation for the 
resulting sex differences in NAM treatment, consulting studies relating to ischemia treatment are 
informative.  
 Sex differences have been reported in the effects of both NAM administration and PARP-
1 inhibition as treatments for ischemia as well as oxidative stress. For example, Siegel and 
McCullough (2013) found that NAM treatment was effective in reducing oxidative stress 
induced damage in male mice, but showed no effects in females. Further, when PARP-1 
knockout animals were tested, they found that the oxidative stress induced damage was 
significantly greater in PARP-1 knockout females while it was decreased in knockout males. 
However, in both PARP-1 knockout males and knockout females, treatment with NAM reduced 
the oxidative stress induced damage. Similar exacerbations of ischemic damage occur in female 
neonatal, adult, and aging female rats when PARP-1 is disrupted or inhibited (Hagberg et al., 
2004; McCullough, Zeng, Blizzard, Debchoudhury, & Hurn, 2005) These results are similar to 
ours in such that our NAM treatment reduced cue-reinstatement in males, but had no effect in 
females indicating that the mechanism by which NAM reduces cue-primed reinstatement is sex 
dependent.   
It is also important to consider that sex differences have also been reported in the baseline 
levels of brain tissue NAD+ in rodents, with females measuring significantly lower levels of 
NAD+ than males; moreover, females do not display the same loss in NAD+ levels after 
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ischemic injury (Siegel & McCullough, 2013). This could be due to the fact that females have 
higher NADH-linked respiration rates in brain mitochondria as NAD+ is reduced to NADH 
during this respiration (Gaignard et al., 2015). These differences suggest that mediation of 
PARP-1 or NAD+ may not be a viable treatment option in females; however, others did report 
that female rats’ infraction volume following ischemic injury was decreased similarly to male 
rats at the same dose and application method of NAM (Sakakibara, Mitha, Ogilvy, & Maynard, 
2000). More research is needed regarding NAM as a viable application in females to reduce 
reinstatement responding. For example, future studies should investigate a variety of NAM doses 
in females to determine if the lack of effects on reinstatement could be related to a difference in 
effective dose.  
Likewise, there are also known sex-dependent differences in the expression of oxidative 
stress. For example, measurement of oxidative stress biomarkers in human subjects who are 
healthy shows females to have lower basal levels of oxidative stress than males (Ide et al., 2002; 
Kander, Cui, & Liu, 2017) and, in rodents exposed to chronic or acute cocaine, females exhibit 
lower DNA damage levels (de Souza et al., 2014). In addition to suggesting that following 
cocaine exposure females my experience lower levels of oxidative stress or simply less oxidative 
stress induced damage, it further suggests that females may also experience lower levels of 
PARP-1 activity in response to oxidative stress. In fact, overall, females seem to be less 
susceptible to oxidative stress and have more antioxidant potential than males (Kander et al., 
2017). However, oxidative stress and PARP-1 activity following cocaine self-administration and 
extinction have not been examined in female rats. Therefore, future studies may examine sex 
differences of oxidative stress and PARP-1 responses to cocaine self-administration as well as 
the sex-dependent divergence of these mechanisms following NAM administration.  
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Mechanism of Action 
 Our results are limited to the behavioral effects of NAM. Based upon the broader 
literature, several functions of NAM could be at play in exerting the effect on cue-primed 
reinstatement, including: PARP-1 inhibition, NAD+ supplementation, and oxidative stress 
reduction. There is, however, some disagreement in the literature surrounding NAM’s function 
as a PARP inhibitor. Specifically, it has been argued that NAM’s ability to inhibit PARP-1 may 
only exist in in vitro testing and not in vivo (Kirkland, 2009). On the other hand, it has been 
suggested that NAM’s function may be dependent upon dosing such that only high doses of 
NAM lead to PARP-1 inhibition (5mM or more) while lower doses result in PARP-1 facilitation 
through provision of NAD+ (Riklis et al., 1990). Facilitation through NAD+ is thought to be 
beneficial due to the fact that PARP-1 activation is followed by NAD+ depletion and a resulting 
ATP depletion due to inhibition of glycolysis (Andrabi et al., 2014; Ying, Garnier, & Swanson, 
2003) in cells including astrocytes (Suh et al., 2007; Tang et al., 2010) and overall brain tissue 
(Cosi & Marien, 1999; Zeng et al., 2007). PARP-1 activation can also lead to mitochondria 
dysfunction, cell death (David, Andrabi, Dawson, & Dawson, 2009; Fatokun, Dawson, & 
Dawson, 2014), and inhibition of astrocytic glutamate uptake capacity (Tang et al., 2010) all of 
which can be prevented by supplicating with NAD+ (Alano, Ying, & Swanson, 2004; Liu, Pitta, 
& Mattson, 2008; Tang et al., 2010).  
Conversely, both deletion of PARP-1 as well as inhibition of PARP-1 is linked to 
increases the cellular content of NAD+ (Bai et al., 2011; Mukhopadhyay et al., 2017), which 
suggests that NAM’s actions as a PARP-1 inhibitor may be inseparable from its ability to 
increase NAD+ availability. However, considering the actions of nicotinamide 
phosphoribosyltransferase (NAMPT), the rate limiting enzyme that converts NAM to 
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nicotinamide mononucleotide (NMN) which can then be converted to NAD+ (Dahl, Holm, 
Aukrust, & Halvorsen, 2012), it seems less likely that an increase of NAD+ would decrease 
cocaine seeking. Although an increase in NAMPT expression reduces ischemic injury in neurons 
(P. Wang et al., 2011), overexpression of NAMPT in the ventral tegmental area (VTA) of mice 
prior to cocaine CPP results in facilitation of cocaine-induced CPP (Kong et al., 2018).  On the 
other hand, inhibition of VTA NAMPT prior to each CPP training session decreases cocaine-
induced CPP and furthermore, the relative VTA content of NAD following CPP correlates with 
observed CPP scores (Kong et al., 2018). Interestingly, since NAMPT functions to convert NAM 
to NMN, inhibition of NAMPT would hypothetically result in an increase of NAM which could 
be working by unknown mechanisms to reduce cocaine CPP in this situation.  The effect of 
NAMPT manipulation on cocaine CPP suggests that a proposed mechanism focusing on NAM’s 
role as an NAD+ precursor would not reduce reinstatement, but would rather facilitate 
reinstatement. Conversely, both deletion of PARP-1 as well as direct inhibition of PARP-1 is 
linked to increases the cellular content of NAD+ (Bai et al., 2011; Mukhopadhyay et al., 2017), 
which suggests that NAM’s actions as a PARP-1 inhibitor may be inseparable from its ability to 
increase NAD+ availability. To our knowledge, however, this has not been directly tested; 
therefore, future studies may investigate whether direct PARP-1 inhibition or supplementation 
with NAD+ is sufficient for attenuating reinstatement as well as whether or not the effects of 
chronic NAM administration are dependent upon either of these mechanisms.  
PARP-1 and gene regulation 
Previous studies in our lab and others have found that GLT-1 mRNA and protein 
expression is down-regulated following cocaine self-administration and extinction (Fischer-
Smith, Houston, & Rebec, 2012; Kim, Sepulveda-Orengo, Healey, Williams, & Reissner, 2018; 
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Knackstedt, Melendez, & Kalivas, 2010). The reduction in mRNA and protein expression of 
GLT-1 is associated with increased methylation of the GLT-1 gene, Slcla2 (Kim et al., 2018).  
PARP-1 has many varied roles in gene regulation including DNA methylation (Kraus & 
Hottiger, 2013). More specifically, PARP-1 regulates the expression and activity of the DNA 
methyltransferase Dnmt1 (Caiafa, Guastafierro, & Zampieri, 2009). While the activity of PARP-
1 has not been directly linked to Slcla2 expression, PARP-1 activation is known to impair 
glutamate uptake activity in cultured astrocytes (Tang et al., 2010)Likewise, interaction of PAR 
with Dnmt1 following cocaine self-administration has not been examined. Therefore, future 
studies can examine how PARP-1 activity may change across time and between different self-
administration models. In addition, future studies may examine the regulatory nature of PARP-1 
on Dmnt1 across time and between different self-administration models.  
In conclusion, evidence presented herein indicates efficacy of NAM against 
responsiveness to drug-paired cues in male rats. Further investigation of the circuitry and cellular 
mechanism of this effect such as PARP-1 inhibition, oxidative stress reduction, and NAD+ 
supplementation will assist in the elucidation of the cellular mechanisms of addiction. Likewise, 
investigation of these mechanisms in females as well as males will contribute to the 
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Figure 1: Chronic NAM administration reduces cue- but not cocaine-primed reinstatement in 
males, but not females. (A) Experimental Timeline. (B) Active and inactive lever presses across 
days during self-administration in male rats (left). Active lever presses between treatment groups 
are shown, right. No differences in active lever presses among treatment groups were seen across 
extinction.  (C) Males who received daily i.p. 120 mg/kg and 60 mg/kg NAM injections 
throughout extinction pressed the active lever significantly less during a test of cue-primed 
reinstatement than those who received daily saline injections throughout extinction (p <0.05). 
Additionally, those in the 120 mg/kg group also pressed significantly less than those in the 10 
mg/kg group (p < 0.05).  (D) Males treated with 0-120 mg/kg NAM during extinction did not 
differ significantly when tested with a cocaine-primed reinstatement session. (E) Active and 
inactive lever presses across days during self-administration in female rats. A main effect of 
lever was observed between active and inactive lever presses (* p < 0.05).  No differences in 
active lever presses among treatment groups were seen across extinction. (F) Females that 
received 120 mg/kg NAM did not differ significantly during a tests of cue-primed or  (G) 
cocaine-primed reinstatement. (H) Ambulatory distance (cm) was measured beginning 30 
minutes after a saline or NAM i.p. injection and continued for two hours. Arrow indicates 10 
mg/kg i.p. cocaine injection given at the 60 minute mark. (I) No significant differences were 
seen between groups during the open field behavior of the first hour (t = 0-60). (J) No significant 
differences were seen between groups following the cocaine injection during the second hour (t = 
60-120). Data shown in H-J are from the same male rats as in B-D. * indicates significant 
difference between active and inactive lever pressing (B) and between treatment groups by post-







































Figure 2:  The effects of chronic NAM administration are specific to cue-primed 
reinstatement.  (A) Experimental timeline. (B) Lever pressing across self-administration and 
extinction. A main effect of lever was observed between active and inactive lever presses (* p < 






































































Figure 3: Acute NAM administration did not affect cue- or cocaine-primed reinstatement. 
 (A) Experimental timeline. (B) Active and inactive lever presses across self-administration and 
extinction. A main effect of lever was observed between active and inactive lever presses (* p < 
0.05). (C) No significant differences between groups were seen during a cue-primed 
reinstatement test after receiving 120 mg/kg injections of NAM thirty minutes prior to the test 
session. (D) No significant differences between groups were seen during the cocaine-primed 






































































































































Figure 4: Chronic NAM administration did not affect cue- or food-primed reinstatement.  
(A) Experimental timeline. (B) Animals reliably self-administered food and extinguished 
responding reliably during extinction. A main effect of lever was observed between active and 
inactive lever presses (* p < 0.05). There was a significant interaction between group and session 
during extinction. Multiple comparisons reveled that the NAM group had significantly fewer 
active lever presses on day 1 of extinction than the saline group (* p <0.0001). Active lever 
pressing the remaining days was not significantly different between groups (p > 0.9999).  (C) No 
significant differences between groups were seen during a cue-primed reinstatement test after 
receiving 120 mg/kg injections of NAM 30 minutes prior to the test session. (D) No significant 
differences between groups were seen during the food-primed reinstatement after receiving 120 
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